GeoVax Labs, Inc.

2.25 USD
-0.09 (-3.65%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

GeoVax Labs, Inc. stock is up 29.02% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 34.48% of the previous 28 June’s closed higher than May. 100% of analysts rate it a buy.

About GeoVax Labs, Inc.

GeoVax Labs, Inc. develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV) and malaria.